In Brief: Coty Reports Q2 Declines; Arden, IFF Make R&D Investments; More
This article was originally published in The Rose Sheet
Executive Summary
Elizabeth Arden and International Flavors and Fragrances invest in a beauty device and “next-generation” encapsulation technology for hair and personal wash applications, respectively. More news in brief.
You may also be interested in...
Skin Devices Poised To Tap “Wealth Of Unrealized Potential” – Kline
Pricing products more economically and expanding distribution are challenges for skin-care device marketers, but there is significant opportunity for firms that can reach consumers at the mass retail level, says Kline & Company. The market for home-use aesthetic devices grew globally by 22% in 2012.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.